Optometrists in Fremont, MI Accepting Medicare

9 Optometrists found. Showing 1 - 9

Dr. Lara Ann Eenigenburg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 103 S Division Ave, Po Box E, Fremont, MI 49412 Phone: 231-924-4110    Fax: 231-924-5007

Dr. Robert Michael Hardy, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1231 W Main St, Fremont, MI 49412 Phone: 231-924-2700    Fax: 231-924-9255

Dr. Rebecca Lynn Payne, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1231 W Main St, Fremont, MI 49412 Phone: 231-924-2700    Fax: 231-924-9255

Robert William Seidel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7083 West 48th St, Fremont, MI 49412 Phone: 231-924-9507    Fax: 231-924-9548

David Wayne Oosting, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9 W Main St, # 10, Fremont, MI 49412 Phone: 231-924-9870    Fax: 231-924-6307

Dr. Jeffrey B Byland, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 103 S Division Ave, Po Box E, Fremont, MI 49412 Phone: 231-924-4110    Fax: 231-924-5007

Dr. Correen Leeann Hayes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1007 W Main St, Fremont, MI 49412 Phone: 231-924-1988    Fax: 231-924-1622

Eye Care One Optometrist Medicare: Medicare Enrolled Practice Location: 1231 W Main St, Fremont, MI 49412 Phone: 231-924-2700    Fax: 231-924-9255

David W. Oosting Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 9 W Main St, Box 10, Fremont, MI 49412 Phone: 231-924-9870    Fax: 231-924-6307

News Archive

New understanding of gestational diabetes

A protein in the pancreas is giving researchers at the Stanford University School of Medicine their first chance at cracking the code that determines how diabetes develops during pregnancy, a finding that could lead to new treatments for all forms of diabetes.

Researchers use new approaches to address premature failure of dental restorations

How can dental restorations - such as fillings and crowns - be made to last longer? A new research group centered at Charité - Universitätsmedizin Berlin and Technische Universität (TU) Berlin plans to address this topic by utilizing approaches from both materials science and dentistry.

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).

Read more Medical News

› Verified 8 days ago